159 related articles for article (PubMed ID: 12916933)
1. Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.
Martin TM; Bandi N; Shulz R; Roberts CB; Kompella UB
AAPS PharmSciTech; 2002; 3(3):E18. PubMed ID: 12916933
[TBL] [Abstract][Full Text] [Related]
2. Polymeric microspheres prepared by spraying into compressed carbon dioxide.
Bodmeier R; Wang H; Dixon DJ; Mawson S; Johnston KP
Pharm Res; 1995 Aug; 12(8):1211-7. PubMed ID: 7494836
[TBL] [Abstract][Full Text] [Related]
3. Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.
Kang Y; Wu J; Yin G; Huang Z; Liao X; Yao Y; Ouyang P; Wang H; Yang Q
Langmuir; 2008 Jul; 24(14):7432-41. PubMed ID: 18547089
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of D, L-PLA loaded 17-β-Estradiol valerate by emulsion/evaporation methods.
Machado SR; Lunardi LO; Tristão AP; Marchetti JM
J Microencapsul; 2009 May; 26(3):202-13. PubMed ID: 18942000
[TBL] [Abstract][Full Text] [Related]
5. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
6. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote AJ; Gupta RB
Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
[TBL] [Abstract][Full Text] [Related]
7. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).
Ghaderi R; Artursson P; Carlfors J
Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010
[TBL] [Abstract][Full Text] [Related]
8. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
9. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
10. Preparation of polymeric submicron particle-containing microparticles using a 4-fluid nozzle spray drier.
Ozeki T; Beppu S; Mizoe T; Takashima Y; Yuasa H; Okada H
Pharm Res; 2006 Jan; 23(1):177-83. PubMed ID: 16267631
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
Young TJ; Johnston KP; Mishima K; Tanaka H
J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
[TBL] [Abstract][Full Text] [Related]
12. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Yeh MK
J Microencapsul; 2000; 17(6):743-56. PubMed ID: 11063421
[TBL] [Abstract][Full Text] [Related]
13. Selection of PLA polymers for the development of injectable prilocaine controlled release microparticles: usefulness of thermal analysis.
Bragagni M; Beneitez C; Martín C; Hernán Pérez de la Ossa D; Mura PA; Gil-Alegre ME
Int J Pharm; 2013 Jan; 441(1-2):468-75. PubMed ID: 23164705
[TBL] [Abstract][Full Text] [Related]
14. Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.
Tom JW; Debenedetti PG
Biotechnol Prog; 1991; 7(5):403-11. PubMed ID: 1369363
[TBL] [Abstract][Full Text] [Related]
15. Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.
Patomchaiviwat V; Paeratakul O; Kulvanich P
AAPS PharmSciTech; 2008; 9(4):1119-29. PubMed ID: 18989787
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
Wichert B; Rohdewald P
J Microencapsul; 1993; 10(2):195-207. PubMed ID: 8392542
[TBL] [Abstract][Full Text] [Related]
17. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
[TBL] [Abstract][Full Text] [Related]
18. Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.
Amini MA; Faramarzi MA; Gilani K; Moazeni E; Esmaeilzadeh-Gharehdaghi E; Amani A
J Microencapsul; 2014; 31(5):422-9. PubMed ID: 24697188
[TBL] [Abstract][Full Text] [Related]
19. Preparation of budesonide/gamma-cyclodextrin complexes in supercritical fluids with a novel SEDS method.
Toropainen T; Velaga S; Heikkilä T; Matilainen L; Jarho P; Carlfors J; Lehto VP; Järvinen T; Järvinen K
J Pharm Sci; 2006 Oct; 95(10):2235-45. PubMed ID: 16883551
[TBL] [Abstract][Full Text] [Related]
20. Supercritical antisolvent precipitation of PHBV microparticles.
Costa MS; Duarte AR; Cardoso MM; Duarte CM
Int J Pharm; 2007 Jan; 328(1):72-7. PubMed ID: 16971075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
